List view / Grid view

Microfluidic Technology

Filter the results



Expert view: Innovations in 3D

15 September 2017 | By

Physiologically relevant models to evaluate the effects of drug candidates early in the drug discovery and development process are becoming increasingly important to develop. Various 3D cell/tissue models have emerged offering relevant environment for ex vivo assays, but significant progress is required to streamline and automate the end-to-end workflow. Several…


Organs-on-chips gearing up to disrupt the microbiome market

16 June 2016 | By

The human microbiome, comprising of the complex and dynamic microbial communities found on the human body, is essential to our health and observed differences in its composition between patients and healthy people have lead to speculations about the involvement of bacteria in disease development. Such differences have provided evidence towards…


EMD Millipore CellASIC® ONIX2 Microfluidic System for live cell imaging

17 March 2016 | By Merck KGaA

The CellASIC® ONIX2 Microfluidic System for live cell imaging is easy to use and gives researchers precise environmental control over live cells. By providing dynamic control over drug addition, gas, temperature, media and more, this all in one system is the perfect addition to your microscope to enhance your imaging…


Microfluidic technology: the next-generation drug discovery tool

21 September 2015 | By ,

Microfluidic miniaturisation, or the so-called ‘lab-on-a-chip’ concept, now encroaches on the fields of biology, medicine and pharmacology, and the nature of microfluidic technology (small volumes and high-throughput integration of fluid connections) means that it is outperforming conventional bench work. There has been an incredible need for microfluidic technology in the…


Formation of nano- and micro-scale drug delivery systems using microfluidic technology

17 October 2014 | By , ,

The recent developments in microfluidic technology have provided an effective microreactor platform for the production of a range of pharmaceutically related materials in both nano- and micro-scale. This can be attributed to the unique characteristics that microfluidic-based reactors offer in terms of controllability and uniformity of the material characteristics, compared…